These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21551873)

  • 1. Substantia nigra grafts and Parkinson's disease: from animal experiments to human therapeutic trials.
    Freed WJ
    Restor Neurol Neurosci; 1991 Jan; 3(3):109-34. PubMed ID: 21551873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with high baseline rotational behavior.
    Heim RC; Willingham G; Freed WJ
    Exp Neurol; 1993 Jul; 122(1):5-15. PubMed ID: 8101821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants.
    Winkler C; Bentlage C; Nikkhah G; Samii M; Björklund A
    Exp Neurol; 1999 Feb; 155(2):165-86. PubMed ID: 10072293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional brain tissue transplantation: reversal of lesion-induced rotation by intraventricular substantia nigra and adrenal medulla grafts, with a note on intracranial retinal grafts.
    Freed WJ
    Biol Psychiatry; 1983 Nov; 18(11):1205-67. PubMed ID: 6652162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain grafts and Parkinson's disease.
    Freed WJ; Poltorak M; Takashima H; LaMarca ME; Ginns EI
    J Cell Biochem; 1991 Mar; 45(3):261-7. PubMed ID: 2066376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic substantia nigra grafts show directional outgrowth to cografted striatal grafts and potential for pathway reconstruction in nonhuman primate.
    Sladek JR; Bjugstad KB; Collier TJ; Bundock EA; Blanchard BC; Elsworth JD; Roth RH; Redmond DE
    Cell Transplant; 2008; 17(4):427-44. PubMed ID: 18522245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
    Baker KA; Hong M; Sadi D; Mendez I
    Exp Neurol; 2000 Apr; 162(2):350-60. PubMed ID: 10739641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adrenal medulla and sciatic nerve co-grafts in rats with unilateral substantia nigra lesions.
    Freed WJ; Willingham G; Heim R
    J Neural Transplant Plast; 1992; 3(2-3):159-67. PubMed ID: 1355367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.
    Kordower JH; Goetz CG; Freeman TB; Olanow CW
    Exp Neurol; 1997 Mar; 144(1):41-6. PubMed ID: 9126150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraparenchymal and intraventricular transplantation of fetal substantia nigra cell suspension in rat model of Parkinson's disease].
    Yang H; Zhang K; Cai W
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):19-21. PubMed ID: 10374501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats.
    Mukhida K; Hong M; Miles GB; Phillips T; Baghbaderani BA; McLeod M; Kobayashi N; Sen A; Behie LA; Brownstone RM; Mendez I
    Brain; 2008 Aug; 131(Pt 8):2106-26. PubMed ID: 18669492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.
    Bartus RT; Brown L; Wilson A; Kruegel B; Siffert J; Johnson EM; Kordower JH; Herzog CD
    Neurobiol Dis; 2011 Oct; 44(1):38-52. PubMed ID: 21704161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice.
    Bye CR; Thompson LH; Parish CL
    Exp Neurol; 2012 Jul; 236(1):58-68. PubMed ID: 22524988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adrenal medulla grafts in neonatal rat hosts on subsequent bilateral substantia nigra lesions.
    Simonds GW; Schwarz S; Krauthamer E; Freed WJ
    Restor Neurol Neurosci; 1990 Jan; 1(5):315-22. PubMed ID: 21551573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.
    Hahn M; Timmer M; Nikkhah G
    J Neurosci Res; 2009 Jul; 87(9):2006-19. PubMed ID: 19235889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.